PULMOPHARMA ApS: Financial statements 2016
CVR: 36428023
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
PULMOPHARMA ApS (CVR 36428023) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2016 report amounted to DKK -2,920.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK -2,920
- Total Assets
- DKK 80
Official annual report
Find more companies like PULMOPHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
PULMOPHARMA ApS has published its interim report for the period November 1, 2014 – December 31, 2015.
About PULMOPHARMA ApS
PULMOPHARMA ApS is a Danish company of the type Anpartsselskab based in Ebeltoft, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dan Mønster Nielsen. The board consists of Torben Ballegaard Sørensen (chair), Dan Mønster Nielsen, Per Bendix Jeppesen and Peter Frithjof Bang. The company's owners include PETER BANG HOLDING ApS, LARS NYENSTAD ApS and BENDIX-HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -49,353 and a net result of DKK -49,353 compared with DKK -20,499 the year before. Equity in the 2025 report amounted to DKK 11,436,934.